11.08.2017
- Ireland-domiciled drugmaker Shire is considering splitting off its neuroscience division into a separate, publicly listed company. The move, revealed during its second-quarter...
03.02.2016
- A key upcoming industry event is DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). DCAT Week brings together pharmaceutical and...
12.01.2016
- In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company...
02.12.2015
- US biopharmaceutical company Baxalta has received European marketing approval for its hemophilia treatment Obizur. The drug is said to be the first recombinant porcine sequence...
04.11.2015
- Ireland-based and London-listed drugmaker Shire has agreed what is being called a “defensive” deal to buy US biotech firm Dyax, which has a breakthrough drug said to threaten one...
05.08.2015
- Irish pharmaceutical producer Shire has made an offer to buy US drugmaker Baxalta for around $30 billion in stock. With the bid, Shire is said to be trying to solidify its position...
